ARCHIVES

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

This article is from The Cancer Letter archive.

Vol. 10 No. 14 | April 6, 1984

Download PDF Visit The Full Archive

Related Articles

Intramural Program Downsizing Expected; Gallin Named Head of Clinical Center

April 15, 1994

NCI To Send Eight To AIDS Conference, Few Will Attend Cancer Meetings

February 28, 1992

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

FDA Committee Approves NDA for Mitxantrone

March 21, 1986

In Brief: Panel Appointments On President’s Desk; Breast Cancer Treatment Workshop Planned

September 14, 1979

Rauscher “Identifies” Four More Comprehensive Centers

June 21, 1974